NCT07372300 2026-01-28
mEHT
Dalin Tzu Chi General Hospital
Phase 3 Recruiting
Clinical Trials
18 trialsNCT07118566 2025-08-12
Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases
China Medical University, China
Phase 2 Not yet recruiting
NCT06831981 2025-02-18
ARO 2024-13
University Hospital Tuebingen
Phase NA Recruiting
NCT02758951 2024-11-25
CAIRO6
Catharina Ziekenhuis Eindhoven
Phase 2/3 Active not recruiting
NCT04889742 2023-12-26
HETERERO
Charite University, Berlin, Germany
Phase 2 Not yet recruiting
NCT06022692 2023-09-05
HEAIS001
Zhejiang Hospital
Phase 1/2 Completed
NCT04104334 2021-10-08
CHIPNOL
Ciusss de L'Est de l'Île de Montréal
Phase NA Terminated
NCT02546596 2021-07-13
The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer
Yonsei Hyperthermia Study Group
Phase NA Unknown
NCT03187587 2021-07-07
Percutaneous Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
Clinical Laserthermia Systems AB
Phase NA Terminated
NCT02973217 2020-12-17
Immunostimulating Interstitial Laser Thermotherapy in Pancreatic Cancer
Clinical Laserthermia Systems AB
Phase NA Completed
NCT00441376 2019-02-07
A Study of ThermoDoxâ„¢ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
Imunon
Phase 1 Completed
NCT02353858 2018-02-13
HT01
University Hospital Tuebingen
Phase 2 Completed
NCT01077427 2017-11-17
HEAT
Klinikum der Universitaet Muenchen, Grosshadern
Phase 3 Unknown
NCT02369939 2017-08-11
HYCAN
University of Erlangen-Nürnberg Medical School
Phase 3 Unknown
NCT02439593 2017-08-01
HEATPAC
Kantonsspital Aarau
Phase 2 Unknown
NCT00052962 2012-11-22
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT00001576 2008-03-04
A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00001587 2008-03-04
A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
National Institutes of Health Clinical Center (CC)
Phase 1 Completed